The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Joanna Wykrzykowska
Showing 1-20 of 62 articles
Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
Kerkmeijer L,
Renkens M,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Garcia-Garcia H,
Kraak R,
Piek J,
Tijssen J,
Henriques J,
de Winter R,
Wykrzykowska J
March 18, 2022 | 10.4244/EIJ-D-21-00419
Ticagrelor or aspirin 1 year after revascularisation: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska J,
Piek J,
Garg S,
Hamm C,
Steg P,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
March 9, 2022 | 10.4244/EIJ-D-21-00870
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K,
Takahashi K,
Asano T,
Katagiri Y,
Hochul M,
Buszman P,
Tomaniak M,
Gorycki B,
Zurakowski A,
Janas A,
Mlodziankowski A,
Kachel M,
Wykrzykowska J,
Wijns W,
de Winter R,
Buszman P,
Onuma Y,
Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial
Kraak R,
Tijssen R,
van Dongen I,
Elias J,
Hofma S,
van der Schaaf R,
Arkenbout EK,
Weevers A,
Tijssen J,
Piek J,
de Winter R,
Henriques J,
Wykrzykowska J
December 4, 2020 | 10.4244/EIJ-D-18-00884
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska J,
de Winter R,
Hamm C,
Steg P,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Quantitative aortography assessment of aortic regurgitation
Modolo R,
Chang C,
Onuma Y,
Schultz C,
Tateishi H,
Abdelghani M,
Miyazaki Y,
Aben J,
Rutten M,
Pighi M,
El Bouziani A,
van Mourik M,
Lemos P,
Wykrzykowska J,
Brito F,
Sahyoun C,
Piazza N,
Eltchaninoff H,
Soliman O,
Abdel-Wahab M,
Van Mieghem N,
de Winter R,
Serruys P
October 9, 2020 | 10.4244/EIJ-D-19-00879
Complex PCI: time for a universal definition
Wykrzykowska J,
Kerkmeijer L
September 18, 2020 | 10.4244/EIJV16I7A100
Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication.
Katagiri Y,
Torii R,
Takahashi K,
Tenekecioglu E,
Asano T,
Chichareon P,
Tomaniak M,
Piek J,
Wykrzykowska J,
Bullett N,
Ahmed N,
Al-Lamee R,
Al-Lamee R,
Leclerc G,
Kitslaar P,
Dijkstra J,
Reiber J,
Poon E,
Bourantas C,
Gijsen F,
Serruys P,
Onuma Y
June 12, 2020 | 10.4244/EIJ-D-18-01190
Clinical outcomes of bioabsorbable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents: two-year follow-up of the DESSOLVE III trial
Katagiri Y,
Onuma Y,
Lurz P,
Buszman P,
Piek J,
Wykrzykowska J,
Asano T,
Kogame N,
Takahashi K,
Chang C,
de Winter R,
Serruys P,
Wijns W
February 7, 2020 | 10.4244/EIJ-D-18-00944
Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation
Katagiri Y,
Serruys P,
Tenekecioglu E,
Asano T,
Collet C,
Miyazaki Y,
Katsikis A,
Piek J,
Wykrzykowska J,
Chevalier B,
Mintz G,
Stone G,
Onuma Y
September 20, 2019 | 10.4244/EIJ-D-18-00422
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
Kerkmeijer L,
Tijssen R,
Hofma S,
van der Schaaf R,
Arkenbout K,
Kraak R,
Weevers A,
Piek J,
de Winter R,
Tijssen J,
Henriques J,
Wykrzykowska J,
Ijsselmuiden A,
Kauer F,
Beijk M,
Vis M,
Koch K
September 20, 2019 | 10.4244/EIJ-D-19-00325
Quantitative aortography for assessing aortic regurgitation after transcatheter aortic valve implantation: results of the multicentre ASSESS-REGURGE Registry
Modolo R,
Chang C,
Tateishi H,
Miyazaki Y,
Pighi M,
Abdelghani M,
Roos M,
Wolff Q,
Wykrzykowska J,
de Winter R,
Piazza N,
Richardt G,
Abdel-Wahab M,
Soliman O,
Onuma Y,
Van Mieghem N,
Serruys P
August 29, 2019 | 10.4244/EIJ-D-19-00362
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska J,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg P,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P,
Farooq V,
Banning AP,
Escaned J,
Wykrzykowska J,
Piek J,
Dudek D,
Ochala A,
Hildick-Smith D,
Goicolea J,
Iñiguez A,
Buszman P,
Modolo R,
Katagiri Y,
Kogame N,
Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials
Katagiri Y,
Serruys P,
Asano T,
Miyazaki Y,
Chichareon P,
Modolo R,
Takahashi K,
Kogame N,
Wykrzykowska J,
Piek J,
Onuma Y
May 20, 2019 | 10.4244/EIJ-D-18-00607
A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial
Asano T,
Jin Q,
Katagiri Y,
Kogame N,
Takahashi K,
Chang C,
Chichareon P,
Wang C,
Shi B,
Su X,
Fu G,
Wu Y,
Zhou X,
Yuan Z,
Wykrzykowska J,
Piek J,
Serruys P,
Onuma Y,
Chen Y
December 20, 2018 | 10.4244/EIJ-D-18-00461
Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study
van Zandvoort L,
Dudek D,
Weber-Albers J,
Abizaid A,
Christiansen E,
Muller D,
Kochman J,
Kołtowski Ł,
Lassen J,
Wojdyla R,
Wykrzykowska J,
Onuma Y,
Daemen J
December 7, 2018 | 10.4244/EIJ-D-18-00491
Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II)
Katagiri Y,
Onuma Y,
Asano T,
Chichareon P,
Collet C,
Miyazaki Y,
Piek J,
Wykrzykowska J,
Abizaid A,
Ormiston J,
Chevalier B,
Serruys P
October 12, 2018 | 10.4244/EIJ-D-18-00301
Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial
Sotomi Y,
Onuma Y,
Liu S,
Asano T,
Eggermont J,
Katagiri Y,
Cavalcante R,
de Winter R,
Wykrzykowska J,
Brugaletta S,
Räber L,
Sabaté M,
Windecker S,
Dijkstra J,
Serruys P
August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T,
Katagiri Y,
Collet C,
Tenekecioglu E,
Miyazaki Y,
Sotomi Y,
Amoroso G,
Aminian A,
Brugaletta S,
Vrolix M,
Hernández-Antolín R,
van de Harst P,
Iñiguez A,
Janssens L,
Smits P,
Wykrzykowska J,
Ribeiro V,
Pereira H,
da Silva P,
Piek J,
Reiber J,
von Birgelen C,
Sabaté M,
Onuma Y,
Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
1
2
3
…
4
Latest news
AHEAD OF PRINT
Catheter-directed thrombolysis in intermediate-high risk acute pulmonary embolism
FREE ARTICLE - Josef Kroupa et al
May 27, 2022
EUROPCR LATE BREAKING
EuroPCR 2022 Late-breaking publications: watch the interviews with the authors!
May 23, 2022
NEW ISSUE
TAVI vs SAVR for bicuspid anatomies; PVR and TAVI; LAA thrombus trapping; crush techniques for bifurcation PCIs; stent elongation in POT and more
May 18, 2022
AHEAD OF PRINT
Delayed hospitalisation in the MITRA-FR trial
FREE ARTICLE - Guillaume Leurent et al
May 25, 2022
AHEAD OF PRINT
Complete cerebral protection during TAVI
FREE ARTICLE - Dariusz Jagielak et al
May 24, 2022
AHEAD OF PRINT
Outcomes of PCI for stent thrombosis
FREE ARTICLE - Mohamed O. Mohamed et al
May 24, 2022
EUROPCR LATE BREAKING
Changes in voice patterns for monitoring heart failure deterioration
FREE ARTICLE - Chaim Lotan et al
May 24, 2022
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke